- Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
Goldman Sachs Future Health Care Equity ETF(GDOC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for GDOC
11/13/2026: GDOC (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Goldman Sachs Future Health Care Equity ETF (GDOC) provides active exposure to global healthcare companies driving structural innovations such as genomics, precision medicine, and digital health. Its main strengths lie in professional active management by Goldman Sachs and targeted exposure to high-conviction disruptive trends. The fund serves as a satellite growth allocation for investors seeking specialized medical sector participation. Key risks include a high expense ratio, concentrated holdings, and sensitivity to regulatory and interest rate pressures. It suits growth-focused investors who want active thematic exposure while monitoring ongoing fund liquidity and performance relative to broad healthcare benchmarks.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The fund targets innovative healthcare companies with high long-term earnings growth potential. |
| Momentum investor | Strong fit while signal remains positive | Momentum suitability depends on an ongoing positive technical upturn across disruptive healthcare equities. |
| Value investor | Weak fit | The portfolio emphasizes growth and disruptive innovation over traditional value metrics. |
| Dividend/Income investor | Weak fit | GDOC focuses on capital appreciation and offers a negligible dividend yield. |
| Low-risk investor | Weak fit | Concentrated active management and exposure to emerging biotech introduce substantial volatility. |
Investor Profile
Ideal Investor Profile
Growth-oriented investors seeking active, thematic exposure to the future of global healthcare and willing to accept higher expense ratios and volatility.
Suitability
Best suited for long-term investors looking to complement a core portfolio with high-conviction healthcare innovation exposure.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | High | Active focus on disruptive medical tech and smaller caps leads to sharp price swings. |
| Market risk | Medium / high | Equities are susceptible to broad healthcare sector downturns and macroeconomic shifts. |
| Concentration | High | The fund holds a limited number of positions, concentrating risk in top holdings. |
| Tracking/expense | Medium / high | An expense ratio of 0.75% requires strong alpha generation to overcome costs. |
| Liquidity | Medium / high | Lower assets under management can result in wider spreads and lower daily trading volume. |
| Business/sector quality | Medium | Relies heavily on the clinical success and regulatory approval paths of underlying innovators. |
Sector & Industry Intelligence
This fund is not assigned to one sector.
Risk Analysis
Volatility
GDOC exhibits elevated historical volatility due to its active exposure to disruptive medical technologies and growth-oriented equities.
Market Risk
The fund is vulnerable to sector-specific regulatory shocks, clinical trial setbacks, and macroeconomic cycles affecting growth assets.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Sector | Global Healthcare Equities (Focus on Genomics, Precision Medicine, and Biotech) | 100 | Provides targeted exposure to disruptive medical technologies and healthcare innovation leaders worldwide. |
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type ETF | Historic Profit 15.59% | Avg. Invested days 43 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

